MegaMD Co

MegaMD Co AAQS

The The AAQS of MegaMD Co (133750.KQ) as of Oct 21, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).

AAQS

1

YoY

0.00%

Last updated:

MegaMD Co has a current AAQS of 1.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock MegaMD Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The MegaMD Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
1.00 KRW
Jan 1, 2019
1.00 KRW
Jan 1, 2020
1.00 KRW
Jan 1, 2021
1.00 KRW
Jan 1, 2022
1.00 KRW
Jan 1, 2023
1.00 KRW
Jan 1, 2024
1.00 KRW
Jan 1, 2025
1.00 KRW
The MegaMD Co AAQS history
YEARAAQSYoY
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
1—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MegaMD Co Stock analysis

What does MegaMD Co do? MegaMD Co., Ltd. generates revenue through test preparation courses for medical education eligibility tests (MEETs), dental education eligibility tests (DEETs), pharmacy education eligibility tests (PEETs), and legal education eligibility tests (LEETs), as well as online education services. The company also sells teaching materials related to these courses. Its primary customers are students preparing for these professional eligibility exams, with a focus on medical, dental, pharmacy, and legal fields. The firm targets individuals seeking certification in these specialized areas through its digital platform. MegaMD's product portfolio includes structured test preparation programs designed for specific professional exams, delivered via online platforms. The company's wholesale of teaching materials complements its course offerings, providing additional resources for students. Revenue streams are derived from course enrollments and material sales, serving a segment of learners dedicated to passing high-stakes professional qualification tests. The business model centers on delivering specialized educational content for four distinct professional fields: medical, dental, pharmacy, and legal. By offering tailored courses for MEETs, DEETs, PEETs, and LEETs, MegaMD addresses the needs of students in these sectors. The company's online delivery model ensures accessibility for a broad audience seeking certification in these regulated professions. MegaMD Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MegaMD Co stock

The AAQS of MegaMD Co is 1 in 2025.

On Eulerpool you can find the complete historical development of The AAQS MegaMD Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — MegaMD Co

All Key Metrics — MegaMD Co